New strategy results in custom “designer proteins” for sensing a variety of molecules
Biosensors are powerful tools in synthetic biology for engineering metabolic pathways or controlling synthetic and native genetic circuits in bacteria. Scientists have had difficulty developing a method to engineer “designer” biosensor proteins that can precisely sense and report the presence of specific molecules, which has so far limited the number and variety of biosensor designs able to precisely regulate cell metabolism, cell biology, and synthetic gene circuits.
But new research published in Nature Methods by a team at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) has leveraged combination of computational protein design, in vitro synthesis and in vivo testing to establish a first-of-its-kind strategy for identifying custom-tailored biosensors.
“Our original motivation for developing customizable biosensors was to get a life or death feedback loop for metabolic engineering,” said George Church, Ph.D., Wyss Institute Core Faculty member, Professor of Genetics at HMS, Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT), and the senior author on the study. “This would essentially give us ‘Darwinian evolution on steroids’, where colonies of bacteria genetically programmed to output a desirable commodity molecule would rapidly become more efficient from generation to generation as only the best metabolic producers will be ‘self-identified’ for survival.”
“This advance represents a powerful new way for us to access the chemical diversity of the biosphere by mining for new pathways to make useful molecules,” said Srivatsan Raman, Ph.D., formerly a Postdoctoral Fellow at the Wyss Institute and HMS and currently Assistant Professor of Biochemistry at University of Wisconsin-Madison, who is the corresponding author on the study.
To develop the method, researchers chose as their test case a natural regulatory protein from E. coli called LacI. LacI is an allosteric transcription factor (aTF), which becomes active in response to sensing “inducer” metabolites or molecules in the bacterium’s environment, thereby triggering expression of a downstream gene. Using LacI, the team set out to develop a framework for re-engineering new biosensor variants that would respond to four inducer molecules (lactitol, sucralose, gentiobiose, and fucose) that cannot be metabolized by natural E. coli. Sucralose, for example, is a completely synthetic sugar molecule sold commercially as Splenda®.
To synthesize and identify the custom-made LacI variants for sensing these four new inducers, the team designed a novel workflow incorporating a combinatorial synthesis strategy that relies on computational protein design and the Wyss Institute’s custom DNA synthesis resources to build a variant library of potential new biosensor designs comprising hundreds of thousands of mutated LacI proteins.
Then, to identify the variants with the most specific responses to the four target molecules of interest, the team engineered groups of E. coli bacteria to express green fluorescent protein (GFP) when the desired molecule was detected, thereby making the bacteria fluoresce. Performing high-throughput in vivo screening of the sensor library in the engineered E. coli, the team identified the most effective variants by their high fluorescence, then filtered them out and genetically sequenced them to reveal the DNA profiles and design maps for transforming aTFs into custom-tailored sensors with high specificity.
The results are striking in that an optimized engineered aTF sensor can be identified for sensing any arbitrary molecule using this approach, opening new doors in synthetic biology by putting allosteric proteins in the control of genetic engineers.
“The LacI protein we chose to re-design into a custom biosensor is only one of thousands of different allosteric transcription factors that exist in nature,” said Noah Taylor, a graduate researcher at the Wyss Institute who recently finished his Ph.D. in Biological and Biomedical Sciences at HMS, and the first author on the study. “The ability to engineer LacI using nothing more than sequence and structure information suggests we could find tens, hundreds, or even thousands of other biosensors that respond to different molecules.”
Biosensors built using this approach provide feedback on how much of a certain metabolite is present inside a cell. Metabolically engineered bacteria can be outfitted with these custom aTFs, enabling them to monitor their own bioproduction of a desired chemical, pharmaceutical or biofuel. This allows sophisticated designs in which the lack of sufficient product could result in the death of an individual cell, eliminating it from the culture. In this way, powerful evolutionary methods can be harnessed for metabolic engineering.
Sensitive detection of metabolites within cells also presents a new paradigm for the way scientists can interrogate single cells. Until now, it has been very challenging to study the metabolic state of a single individual cell. But designer biosensors could be utilized as custom responders to metabolites of interest, giving insight into the metabolic states of live cells in close to real time.
“We are now utilizing the method to find biosensors for a variety of high-value targets, particularly those that can aid in protecting the environment,” said Alexander Garruss, co-author on the study, who is a graduate researcher at the Wyss Institute and a Ph.D. candidate in Bioinformatics and Integrative Genomics at HMS.
Beyond measuring metabolites within cells, the combinatorial synthesis approach paves a path forward toward designing countless new and highly specific biological sensors for novel applications such as environmental monitoring, medical diagnostics, bioremediation, and precision gene therapies.
Learn more: Biosensors on demand
The Latest on: Biosensors
via Google News
The Latest on: Biosensors
- Bangladesh Tumor Marker Sales Segment Forecasts for over 40 Tests, 2019 - DNA Probes, Chromosome Analysis, AI & Biosensors - ResearchAndMarkets.comon January 10, 2020 at 12:52 am
DUBLIN--(BUSINESS WIRE)--The "Bangladesh Tumor Marker Sales Segment Forecasts for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and ...
- Biosensor Market 2020 Global Trends, Industry Share, Supply, Demand, Size, Growth and Forecast to 2025|MRE Analysison January 9, 2020 at 11:21 pm
New York, January 10, 2020: Biosensors have emerged because the most potential analytical tools used for the detection of an analytic with the assistance of a physiochemical detector. Though ...
- Wearable Biosensors Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 – Market Research Engineon January 9, 2020 at 10:50 pm
New York, January 10, 2020: The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled ...
- Croatia Tumor Marker Sales Segment Forecasts for over 40 Tests: Monoclonal Antibodies, DNA Probes, AI & Biosensors - ResearchAndMarkets.comon January 9, 2020 at 4:24 am
DUBLIN--(BUSINESS WIRE)--The "Croatia Tumor Marker Sales Segment Forecasts for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities ...
- At 10.4% of CAGR, Biophotonics Market Expected to Reach $63.1 Billion By 2022on January 8, 2020 at 8:55 pm
Biophotonics Market Outlook – 2022 The global biophotonics market size is estimated to reach $63.1 billion by 2022 from $31.6 billion in 2015, growing at a CAGR of 10.4% from ...
- What are Electrochemical Biosensors?on January 8, 2020 at 3:10 am
Electrochemical biosensors are a class of biosensors that function using an electrochemical transducer. They can detect biological materials such as enzymes, whole cells, specific ligands, and tissues ...
- In the 2020s, tiny biosensors could make a 911 phone call from Marson December 25, 2019 at 4:00 pm
That’s why they’re constantly looking for ways their inventions could work on Earth. By the end of the next decade, NASA scientists are hoping that the biosensors they’re developing today will be as ...
- Biosensors could save future astronauts before they're in dangeron December 18, 2019 at 4:00 pm
Thanks to developments in biosensors that NASA and outside group NextFlex are working on today, Anxious or Unhealthy Astronaut might be able to figure out what’s ailing them at speeds unimaginable ...
- Biosensors Market Analysis, Top Key Players, Target Audience and Forecast to 2026on December 18, 2019 at 1:58 am
The report is readily available and can be dispatched immediately after payment confirmation.
- Living biosensors and micromotors as platform for precision medicineon December 16, 2019 at 1:57 am
Optical biosensors and micromotors that can sense and actuate biological environments are considered promising theranostic devices because of their high spatial resolution and flexibility. Advancing ...
via Bing News